The Froedtert Menomonee Falls Hospital Breast Tumor Board is a multidisciplinary discussion of specific breast cancer/tumor cases including clinical trials with the objective to improve patient outcomes. This series is an opportunity to learn about new treatment options and guidelines.
Key Words: Breast, Tumor, Cancer, Patient Outcomes
- Nurse Practitioner
- Physician Assistant
- Social Worker
Participants who engage in this educational intervention will be able to:
- Collaboratively discuss and implement best practices with an improved understanding of the specific cases presented.
In accordance with the ACCME® Standards for Integrity and Independence in Accredited Continuing Education, Standard 3, all in control of content must disclose any relevant financial relationships. The following in control of content had no relevant financial relationships to disclose.
Abdel Alqwasmi, MD, Staff Physician in the Multi-Specialty department at Medical College of Wisconsin
ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 1.00 hours of participation for continuing education for allied health professionals.
The Medical College of Wisconsin, Inc. is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners: AANP Provider Number 150930. This program has been approved for up to 1.00 contact hours of continuing education (which includes 1.00 hours of pharmacology). Nurse Practitioners should claim only those hours actually spent participating in the CME activity.